Special Engineer

Department of Cancer Immunology, Institute of Cancer Research, Oslo University Hospital; Oslo fylke; On-site; NOK 700,000 - 900,000; Full time

Benefits offered by this job

Industry-academic collaboration

Salary according to OUH scale

Welfare benefits

Job summary

The Department of Cancer Immunology at Oslo University Hospital's Institute of Cancer Research seeks a research engineer (spesialingeniør) in molecular and cell biology to join Prof. Mouldy Sioud's group.

You will design and conduct in vitro/in vivo experiments, analyze data, and contribute to publications, aiming to identify cell-surface receptors involved in antibody binding to cancer cells and enhance mRNA cancer vaccines.

Qualifications

• Master's degree in molecular biology, cell biology, biotechnology, immunology, or a related field.
• Practical experience in molecular and cellular biology including cell culture, transfection, cloning, and protein analysis.
• Experience with flow cytometry, immunoprecipitation, tagged protein purification, and immunological techniques is desirable.

Responsibilities

• Design and conduct in vitro and in vivo experiments; analyze data and contribute to publications.
• Identify cell-surface receptors involved in antibody binding to cancer cells.
• Enhance efficacy of mRNA-based cancer vaccines through modifications.

Skills

Molecular biology

Cell biology

Communication skills

Independent work

Education

Master's degree in molecular biology or related field

Tools

Flow cytometry

Immunoprecipitation

Protein analysis

Cell culture

Cloning

Job description

Department of Cancer Immunology, Institute of Cancer Research, Oslo University Hospital

A research engineer (spesialingeniør) position in molecular and cell biology is available in the research group targeted therapies and immunomodulation headed by Prof. Mouldy Sioud, Department of Cancer Immunology, Institute of Cancer Research, Oslo University Hospital-Radiumhospitalet.

The research group focuses on the development of new cancer therapeutics such as antibodies, antibody derivatives, and modified mRNA cancer vaccines using in vitro screening platforms and cell and molecular techniques. The position will provide a unique opportunity to pursue basic and translational research with the aim to identify novel targets and strategies for cancer immunotherapy.

Further information on the activity of the research group can be accessed at http://ous-research.no/sioud/ .To date, the group has published 220 scientific papers, all of which are indexed in PubMed.

A research engineer (spesialingeniør) position in molecular and cell biology is available in the research group targeted therapies and immunomodulation headed by Prof. Mouldy Sioud, Department of Cancer Immunology, Institute of Cancer Research, Oslo University Hospital-Radiumhospitalet.

The research group focuses on the development of new cancer therapeutics such as antibodies, antibody derivatives, and modified mRNA cancer vaccines using in vitro screening platforms and cell and molecular techniques. The position will provide a unique opportunity to pursue basic and translational research with the aim to identify novel targets and strategies for cancer immunotherapy.

Further information on the activity of the research group can be accessed at http://ous-research.no/sioud/ .To date, the group has published 220 scientific papers, all of which are indexed in PubMed.

Oslo University Hospital is a workplace with great diversity. We believe this is crucial for solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and we encourage all qualified candidates, regardless of background, to apply!

Position Description

The successful candidate will work closely with the group leader and other team members to design and conduct a range of in vitro and in vivo experiments, analyse experimental data, and contribute to scientific publications. The main aim is to identify cell-surface receptors involved in antibody binding to cancer cells and enhance the efficacy of mRNA-based cancer vaccines through mRNA modifications

The position is available for one year with the possibility for extension based on the candidate performance.

Requirements

• Master's degree in molecular biology, cell biology, biotechnology, immunology, or a related field
• Practical experience in molecular and cellular biology, including cell culture, transfection, cloning, and protein analysis
• Experience with flow cytometry, immunoprecipitation, tagged protein purification, and/ or immunological techniques is highly desirable
• Good communication skills in English and the ability to work independently and collaboratively

We offer

• A varied and exciting work in an environment in the intersection between research and industry, developing novel cancer treatments
• A productive and motivating research environment
• Attractive welfare benefits
• Salary according to the OUS salary scale

Kontaktinformasjon

Mouldi Sioud,Enhetsleder, [e-mail]

Arbeidssted

Ullernchausseen 70

0310Oslo

Nøkkelinformasjon:

Arbeidsgiver: Oslo universitetssykehus HF

Referansenr.: 5195633177

Stillingsprosent: 100%

Contract

Startdato: 15.01.2027

Sluttdato: 14.01.2028

Søknadsfrist: 15.11.2026

Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavia’s largest hospital, we carry out more than 1.2 million patient treatments each year. The hospital has a nationwide responsibility for a number of national and multi-regional assignments, and has several national centers of competence. Oslo University Hospital is responsible for approximately 50 percent of all medical and health care research conducted at Norwegian hospitals, and is a significant role player within the education of a large variety of health care personnel.